SeaStar Medical Holding Corp (ICU)

Currency in USD
0.235
-0.022(-8.55%)
Closed·
0.210-0.025(-10.64%)
·
Unusual Post-Market activity
ICU is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.2350.275
52 wk Range
0.2323.070
Key Statistics
Prev. Close
0.235
Open
0.275
Day's Range
0.235-0.275
52 wk Range
0.232-3.07
Volume
2.79M
Average Volume (3m)
2.62M
1-Year Change
-88.19%
Book Value / Share
0.41
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ICU Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
1.000
Upside
+325.53%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

SeaStar Medical Holding Company Profile

SeaStar Medical Holding Corporation, a commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.

SeaStar Medical Holding Corp Earnings Call Summary for Q3/2025

  • SeaStar Medical's Q3 2025 revenue reached $183,000 (up from $68,000 in Q3 2024) with a 92% gross profit margin, despite posting a $3.5 million net loss ($0.13 per share).
  • The company expanded its NEUTRALIZE-AKI clinical trial enrollment and launched a new trial for cardiorenal syndrome, targeting completion by end of 2026.
  • Management projects full-year revenue to exceed $1 million and aims to capture a significant share of the estimated $100 million U.S. pediatric AKI market.
  • SeaStar Medical plans to expand its network to 20 new pediatric hospitals and will present at the JP Morgan Conference in January 2026.
  • Despite a 7.85% stock price decline during regular trading (closing at $0.499), shares rose 2.2% in aftermarket trading to $0.51.
Last Updated: 13/11/2025, 22:28
Read Full Transcript

Compare ICU to Peers and Sector

Metrics to compare
ICU
Peers
Sector
Relationship
P/E Ratio
−0.6x22.0x−0.6x
PEG Ratio
−0.010.070.00
Price/Book
0.7x8.2x2.6x
Price / LTM Sales
9.6x5.6x3.2x
Upside (Analyst Target)
325.5%32.0%41.8%
Fair Value Upside
Unlock11.5%5.1%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 1.000
(+325.53% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Nov 13, 2025
EPS / Forecast
-0.13 / -0.34
Revenue / Forecast
183.00K / --
EPS Revisions
Last 90 days

People Also Watch

1.4600
INHD
-7.59%
3.3600
PCSA
-6.67%
0.46
VSEE
+4.49%
1.160
KTTA
-1.69%
0.3500
VRAX
-9.09%

FAQ

What Is the SeaStar Medical Holding (ICU) Share Price Today?

The live SeaStar Medical Holding share price today is 0.235

What Stock Exchange Does SeaStar Medical Holding (ICU) Trade On?

SeaStar Medical Holding is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for SeaStar Medical Holding?

The stock symbol (also called a 'ticker') for SeaStar Medical Holding is "ICU."

What Is the Current SeaStar Medical Holding Market Cap?

As of today, SeaStar Medical Holding market capitalisation is 8.48M.

What Is SeaStar Medical Holding's (ICU) Earnings Per Share (TTM)?

The SeaStar Medical Holding EPS is currently -1.06 (Trailing Twelve Months).

Is ICU a Buy or Sell From a Technical Analyst Perspective?

Based on today's SeaStar Medical Holding moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has SeaStar Medical Holding Stock Split?

SeaStar Medical Holding has split 1 times. (See the ICU stock split history page for full effective split date and price information.)

How Many Employees Does SeaStar Medical Holding Have?

SeaStar Medical Holding has 19 employees.

What is the current trading status of SeaStar Medical Holding (ICU)?

As of 24 Dec 2025, SeaStar Medical Holding (ICU) is trading at a price of 0.235, with a previous close of 0.235. The stock has fluctuated within a day range of 0.235 to 0.275, while its 52-week range spans from 0.232 to 3.070.

What Is SeaStar Medical Holding (ICU) Price Target According to Analysts?

The average 12-month price target for SeaStar Medical Holding is USD1, with a high estimate of USD1 and a low estimate of USD1. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +325.53% Upside potential.

What Is the ICU After Hours Price?

ICU's last after hours stock price is 0.210, the stock has decreased by -0.025, or -10.640%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.